メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment

  • Shazia Ashraf
  • , Hiroki Kudo
  • , Jia Rao
  • , Atsuo Kikuchi
  • , Eugen Widmeier
  • , Jennifer A. Lawson
  • , Weizhen Tan
  • , Tobias Hermle
  • , Jillian K. Warejko
  • , Shirlee Shril
  • , Merlin Airik
  • , Tilman Jobst-Schwan
  • , Svjetlana Lovric
  • , Daniela A. Braun
  • , Heon Yung Gee
  • , David Schapiro
  • , Amar J. Majmundar
  • , Carolin E. Sadowski
  • , Werner L. Pabst
  • , Ankana Daga
  • Amelie T. Van Der Ven, Johanna M. Schmidt, Boon Chuan Low, Anjali Bansal Gupta, Brajendra K. Tripathi, Jenny Wong, Kirk Campbell, Kay Metcalfe, Denny Schanze, Tetsuya Niihori, Hiroshi Kaito, Kandai Nozu, Hiroyasu Tsukaguchi, Ryojiro Tanaka, Kiyoshi Hamahira, Yasuko Kobayashi, Takumi Takizawa, Ryo Funayama, Keiko Nakayama, Yoko Aoki, Naonori Kumagai, Kazumoto Iijima, Henry Fehrenbach, Jameela A. Kari, Sherif El Desoky, Sawsan Jalalah, Radovan Bogdanovic, Nataša Stajić, Hildegard Zappel, Assel Rakhmetova, Sharon Rose Wassmer, Therese Jungraithmayr, Juergen Strehlau, Aravind Selvin Kumar, Arvind Bagga, Neveen A. Soliman, Shrikant M. Mane, Lewis Kaufman, Douglas R. Lowy, Mohamad A. Jairajpuri, Richard P. Lifton, York Pei, Martin Zenker, Shigeo Kure, Friedhelm Hildebrandt

研究成果: ジャーナルへの寄稿学術論文査読

抄録

No efficient treatment exists for nephrotic syndrome (NS), a frequent cause of chronic kidney disease. Here we show mutations in six different genes (MAGI2, TNS2, DLC1, CDK20, ITSN1, ITSN2) as causing NS in 17 families with partially treatment-sensitive NS (pTSNS). These proteins interact and we delineate their roles in Rho-like small GTPase (RLSG) activity, and demonstrate deficiency for mutants of pTSNS patients. We find that CDK20 regulates DLC1. Knockdown of MAGI2, DLC1, or CDK20 in cultured podocytes reduces migration rate. Treatment with dexamethasone abolishes RhoA activation by knockdown of DLC1 or CDK20 indicating that steroid treatment in patients with pTSNS and mutations in these genes is mediated by this RLSG module. Furthermore, we discover ITSN1 and ITSN2 as podocytic guanine nucleotide exchange factors for Cdc42. We generate Itsn2-L knockout mice that recapitulate the mild NS phenotype. We, thus, define a functional network of RhoA regulation, thereby revealing potential therapeutic targets.

本文言語英語
論文番号1960
ジャーナルNature communications
9
1
DOI
出版ステータス出版済み - 01-12-2018
外部発表はい

All Science Journal Classification (ASJC) codes

  • 化学一般
  • 生化学、遺伝学、分子生物学一般
  • 一般
  • 物理学および天文学一般

フィンガープリント

「Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル